Log in or Sign up for Free to view tailored content for your specialty!
Pediatric ID News
Hooked on ID with Brandon J. Smith, MD, PharmD
Why ID? Cue the iconic theme music from the medical drama House.
Q&A: CDC recommends testing all children exposed to hepatitis C
The CDC this week recommended hepatitis C testing for all infants or children who were perinatally exposed to the virus by a pregnant person with a current or probable HCV infection.
Log in or Sign up for Free to view tailored content for your specialty!
Single dose of benzathine penicillin effective against early syphilis
BOSTON — A single dose of benzathine penicillin G is effective against early syphilis regardless of HIV status, according to a study presented at IDWeek.
Study: Pediatric mental health emergencies increased with each COVID-19 wave in NYC
Pediatric mental health emergencies increased with each COVID-19 wave in New York City, a study in Pediatrics found.
Researchers infect women with Zika virus to help find a vaccine
Researchers completed the first ever human challenge trial for Zika virus, deliberately infecting volunteers to identify strains of the virus that can be safely used to test vaccines against the mosquito-borne pathogen.
Black children more likely to die of sepsis at one hospital
WASHINGTON — Black children were more than twice as likely to die of sepsis as white children at one Arkansas hospital, according to research presented at the AAP National Conference & Exhibition.
CDC committee recommends new pentavalent meningococcal vaccine
A CDC advisory committee voted 10-4 on Wednesday to recommend administering a newly approved pentavalent meningococcal vaccine when vaccination with both a MenACWY and MenB vaccine are indicated at the same visit.
FDA will review self-administered flu vaccine for approval
The FDA is set to review what could be the country’s first self-administered influenza vaccine.
In Africa, PEPFAR countries test more for COVID-19, showing impact of investment
BOSTON — Sub-Saharan African countries supported by the U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, tested for COVID-19 at three times the rate of non-PEPFAR nations, according to data presented at IDWeek.
Protection from nirsevimab may last longer than an RSV season
Nirsevimab, a monoclonal antibody recently approved to prevent respiratory syncytial virus-associated lower respiratory disease in newborns and infants, may protect longer than an RSV season, researchers reported at IDWeek.